Answers are grounded in this paper and cite their sources.
The relatively poor tolerability of the centrally-acting drugs carbamazepine and oxcarbazepine highlights the need to develop new selective and better-tolerated sodium-channel blockers. Prospective studies based on more advanced neuroimaging techniques should focus on how trigeminal anatomical abnormalities may be able to predict the efficacy of microvascular decompression.
No takes yet. Share an insight, caveat, or question.
Stefano et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: